Healthcare ❯Vaccination

COVID-19 Vaccines

Variants Vaccine Development Public Health Recommendations Access Programs Mandates Pfizer and Moderna Public Response FDA Approval Vaccine Effectiveness Effectiveness mRNA Vaccines Public Health Response Vaccine Efficacy

US Confirms NB.1.8.1 Variant in Travel-Linked Cases and Tightens Vaccine Guidance

FDA will narrow COVID-19 vaccine eligibility to seniors and medically vulnerable after WHO classifies NB.1.8.1 as a variant under monitoring.

New COVID Variant NB.1.8.1 Monitored in U.S. After Driving Surges in Asia

EMA Recommends Updated Covid Vaccines to Target LP.8.1 Variant as Cases Rise

New COVID-19 Variants KP.3.1.1 and XEC Spread Rapidly

Free COVID-19 Tests Available for US Households Starting Late September

COVID-19 Levels Surge in Wastewater Across 27 States

COVID-19 Drops to 10th Leading Cause of Death in US for 2023

New COVID Variant KP.2 Emerges as Dominant Strain

U.S. Faces Rise of New COVID FLiRT Variants Amid Low Vaccination Rates